CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial

DOI: 10.1080/2162402X.2018.1440169

Keywords: Adoptive T cell therapies, advanced metastasis malignancies, autologous T cells, CD133, chimeric antigen receptor (CAR), phase I trial, therapeutic trials

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text